| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Development
1 company
Hewitt James is a SVP Development at MDRX. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $2.6M at current prices.
Hewitt James's largest disclosed position is in MDRX as SVP Development, worth about $2.6M. The recent filings there lean toward selling, a net 159,296 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2017 | MDRX Veradigm Inc. | SVP Development | Sell | 36,796 | $14.11 | $519,084.85 | -16.8% | |
| Sep 15, 2016 | MDRX Veradigm Inc. | SVP Development | Sell | 17,500 | $13.00 | $227,500.00 | -10.0% | |
| Jul 1, 2016 | MDRX Veradigm Inc. | SVP Development | Sell | 17,500 | $13.00 | $227,500.00 | -9.1% | |
| Mar 30, 2016 | MDRX Veradigm Inc. | SVP Development | Sell | 17,500 | $13.31 | $232,925.00 | -7.1% | |
| Aug 17, 2015 | MDRX Veradigm Inc. | SVP Development | Sell | 70,000 | $14.17 | $991,655.00 | -27.9% |